Cortex announced today that it began its RESOLVE-AF trial evaluating its Ablamap system with the newly released Ablacath mapping technology. Launched by Ajax Health in December 2023, the company already offers the FDA-cleared Ablamap with electrographic flow (EGF). It seeks to pair the system with the newly released Ablacath mapping catheter to identify extra-pulmonary vein […]
Cortex
Ajax Health launches new pulsed-field ablation company called Cortex
Ajax Health announced today that it formed and provided funding for Cortex, a new developer of ablation technology for treating AFib. Cortex launches with $90 million in funding commitments, led by KKR and Hellman & Friedman. AI Life Sciences and other investors also participated in this initial funding. KKR and H&F invested through the Cordis […]
